GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altimmune Inc (NAS:ALT) » Definitions » E10

ALT (Altimmune) E10 : $-26.33 (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Altimmune E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Altimmune's adjusted earnings per share data for the three months ended in Dec. 2024 was $-0.330. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-26.33 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was 13.40% per year. During the past 5 years, the average E10 Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Altimmune was 53.00% per year. The lowest was 7.90% per year. And the median was 30.40% per year.

As of today (2025-03-14), Altimmune's current stock price is $5.92. Altimmune's E10 for the quarter that ended in Dec. 2024 was $-26.33. Altimmune's Shiller PE Ratio of today is .


Altimmune E10 Historical Data

The historical data trend for Altimmune's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altimmune E10 Chart

Altimmune Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.08 -40.51 -39.25 -32.06 -26.33

Altimmune Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.06 -31.09 -30.91 -27.88 -26.33

Competitive Comparison of Altimmune's E10

For the Biotechnology subindustry, Altimmune's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Altimmune's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Altimmune's Shiller PE Ratio falls into.



Altimmune E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Altimmune's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.33/133.1571*133.1571
=-0.330

Current CPI (Dec. 2024) = 133.1571.

Altimmune Quarterly Data

per share eps CPI Adj_EPS
201503 6.000 99.621 8.020
201506 -12.000 100.684 -15.870
201509 -6.000 100.392 -7.958
201512 -6.000 99.792 -8.006
201603 -6.000 100.470 -7.952
201606 -7.500 101.688 -9.821
201609 -21.300 101.861 -27.844
201612 -13.800 101.863 -18.040
201703 -20.400 102.862 -26.408
201706 -7.800 103.349 -10.050
201709 -61.570 104.136 -78.729
201712 -16.150 104.011 -20.676
201803 -7.490 105.290 -9.472
201806 -10.290 106.317 -12.888
201809 -1.730 106.507 -2.163
201812 -2.786 105.998 -3.500
201903 -0.270 107.251 -0.335
201906 -0.260 108.070 -0.320
201909 -0.740 108.329 -0.910
201912 -0.250 108.420 -0.307
202003 -0.260 108.902 -0.318
202006 -0.940 108.767 -1.151
202009 -0.540 109.815 -0.655
202012 -0.170 109.897 -0.206
202103 -0.380 111.754 -0.453
202106 -0.600 114.631 -0.697
202109 -0.810 115.734 -0.932
202112 -0.570 117.630 -0.645
202203 -0.440 121.301 -0.483
202206 -0.420 125.017 -0.447
202209 -0.480 125.227 -0.510
202212 -0.430 125.222 -0.457
202303 -0.400 127.348 -0.418
202306 -0.320 128.729 -0.331
202309 -0.390 129.860 -0.400
202312 -0.560 129.419 -0.576
202403 -0.340 131.776 -0.344
202406 -0.350 132.554 -0.352
202409 -0.320 133.029 -0.320
202412 -0.330 133.157 -0.330

Add all the adjusted EPS together and divide 10 will get our e10.


Altimmune  (NAS:ALT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Altimmune E10 Related Terms

Thank you for viewing the detailed overview of Altimmune's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Altimmune Business Description

Traded in Other Exchanges
Address
910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
Executives
David Drutz director 8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615
Richard I Eisenstadt officer: Chief Financial Officer 4819 EMPEROR BOULEVARD, SUITE 400, DURHAM NC 27703
Catherine A. Sohn director C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2
Matthew Scott Harris officer: Chief Medical Officer C/O ALTIMMUNE, INC., 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
Raymond M Jordt officer: Chief Business Officer ALTIMMUNE, INC., 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
Wayne Pisano director C/O PROVENTION BIO, INC., P.O. BOX 666, OLDWICK NJ 08858
Vipin K Garg director, officer: President and CEO 4819 EMPEROR BOULEVARD, SUITE 400, DURHAM NC 27703
John Gill director C/O PHARMATHENE, INC, ONE PARK PLACE, SUITE 450, ANNAPOLIS MD 21401
M Scot Roberts officer: Chief Scientific Officer 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
Diane Jorkasky director 60 MANOR AVENUE, WELLESLEY MA 02482
Philip Hodges director 19 FIRSTFIELD RD., SUITE 200, GAITHERSBURG MD 20878
Vhcp Management Iii, Llc 10 percent owner 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Venrock Healthcare Capital Partners Ii, L.p. 10 percent owner 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Venrock Healthcare Capital Partners Iii, L.p. 10 percent owner 530 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10036
Vhcp Co-investment Holdings Iii, Llc 10 percent owner 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018